BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Queensland Health
US Army
Boehringer Ingelheim

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,933,097

« Back to Dashboard

Which drugs does patent 8,933,097 protect, and when does it expire?

Patent 8,933,097 protects CHILDREN'S ALLEGRA ALLERGY and CHILDREN'S ALLEGRA HIVES and is included in one NDA.

This patent has thirty-eight patent family members in thirty-six countries.

Summary for Patent: 8,933,097

Title:Fexofenadine suspension formulation
Abstract: The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.
Inventor(s): Chrzan; Kazimierz (New Hope, PA), Haribhakti; Rajiv (Churchville, PA), Mermey; Matthew (Leawood, KS), Porcello; Curtis J. (Ewing, NJ), Silvey; Gary Lee (Overland Park, KS), Tran; Vinh (Leawood, KS), Agrawala; Prafulla (Kendall Park, NJ)
Assignee: Sanofi-Aventis U.S. LLC (Bridgewater, NJ)
Application Number:12/138,468
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Aventis Us
fexofenadine hydrochloride
SUSPENSION;ORAL201373-001Jan 24, 2011OTCYesYes► Subscribe► SubscribeY
Sanofi Aventis Us
fexofenadine hydrochloride
SUSPENSION;ORAL201373-002Jan 24, 2011OTCYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,933,097

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal1965768► Subscribe
Peru10032007► Subscribe
New Zealand568943► Subscribe
Norway339877► Subscribe
Norway20082904► Subscribe
Malaysia146988► Subscribe
Morocco30152► Subscribe
South Korea101452792► Subscribe
South Korea20080074180► Subscribe
Japan5308824► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Argus Health
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus